Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure.

Basoglu, M; Marks, I M; Swinson, R P; Noshirvani, H; O'Sullivan, G; Kuch, K

Basoglu, M; Marks, I M; Swinson, R P; Noshirvani, H; O'Sullivan, G; Kuch, K.

Affiliation

Basoglu M; Institute of Psychiatry, University of London, UK.

J Affect Disord ; 30(2): 123-32, 1994 Feb.

Article in En | MEDLINE | ID: mdl-7911132

Subject(s)

Agoraphobia/therapy; Alprazolam/administration & dosage; Desensitization, Psychologic; Panic Disorder/therapy; Adult; Agoraphobia/psychology; Alprazolam/adverse effects; Combined Modality Therapy; Depressive Disorder/psychology; Depressive Disorder/therapy; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder/psychology; Personality Assessment/statistics & numerical data; Prognosis; Psychometrics; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Alprazolam / Panic Disorder / Agoraphobia / Desensitization, Psychologic Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Affect Disord Year: 1994 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links